Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis

BACKGROUND: A Phase I, single-center investigation found that 8 weeks of antimycobacterial therapy improved sarcoidosis FVC. Safety and efficacy assessments have not been performed in a multicenter cohort. RESEARCH QUESTION: The objective of this study was to determine the safety and efficacy of ant...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Chest
Prif Awduron: Drake, Wonder P., Culver, Daniel A., Baughman, Robert P., Judson, Marc A., Crouser, Elliott D., James, W. Ennis, Ayers, Gregory D., Ding, Tan, Abel, Kenny, Green, Abena, Kerrigan, Amy, Sesay, Ahmed, Bernard, Gordon R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American College of Chest Physicians 2021
Pynciau:
Diffuse Lung Disease: Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129732/
https://ncbi.nlm.nih.gov/pubmed/33387486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.12.027
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg